You are here

  • Home
  • Archive
  • Volume 1, Issue 2
  • Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial

Article info

Article menu

Download PDFPDF

Original article
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial

Authors

  • David Wang Illinois Neurological Institute Stroke Network, Sisters of the Third Order of St. Francis Healthcare System, University of Illinois College of Medicine, Peoria, Illinois, USA PubMed articlesGoogle scholar articles
  • Li Gui Southwest Hospital Stroke Center, Third Military University of Medical Sciences, Chongqing, China PubMed articlesGoogle scholar articles
  • Yi Dong Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Hao Li China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Shujuan Li Chaoyang Hospital Neurology Department, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Huaguang Zheng Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Anxin Wang China National Clinical Research Center for Neurological Diseases, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Xia Meng China National Clinical Research Center for Neurological Diseases, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Li-Ping Liu Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China Neurological Intensive Care Unit, Beijing Tiantan Hospital, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Yi-Long Wang China National Clinical Research Center for Neurological Diseases, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Guangyao Wang China National Clinical Research Center for Neurological Diseases, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Jing Jing Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China Neurological Intensive Care Unit, Beijing Tiantan Hospital, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Zixiao Li China National Clinical Research Center for Neurological Diseases, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Xing-Quan Zhao China National Clinical Research Center for Neurological Diseases, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Yong-Jun Wang China National Clinical Research Center for Neurological Diseases, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Tiantan Clinical Trial and Research Center for Stroke, Capital Medical University, Beijing, China Department of Neurology, Beijing Tiantan Hospital, Vascular Neurology, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Yong-Jun Wang; yongjunwang1962{at}gmail.com
View Full Text

Citation

Wang D, Gui L, Dong Y on behalf of the investigators for the CHANCE trial, et al
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
Stroke and Vascular Neurology 2016;1:doi: 10.1136/svn-2016-000008

Publication history

  • Received January 6, 2016
  • Revised April 22, 2016
  • Accepted May 9, 2016
  • First published June 16, 2016.
Online issue publication 
May 01, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/